Word

AMPEL ANALYTICS

Status

Pending

Status Code

732

Status Date

Friday, October 6, 2023

Serial Number

90680751

Mark Type

4000

Filing Date

Thursday, April 29, 2021

Published for Opposition

Tuesday, February 15, 2022

Trademark Owner History

Ampel, LLC - Owner At Publication

Classifications

44 Medical information services, namely, providing reports and information relating to disease activity in individuals suffering from autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases based on their genetic profiles and gene expression; Providing reports and information relating to the best drug therapies and treatment options for individuals with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases based on their genetic profile and gene expression

"ANALYTICS"

Trademark Events

Oct 10, 2023

Notice Of Approval Of Extension Request E-Mailed

Oct 6, 2023

Sou Extension 3 Granted

Oct 6, 2023

Sou Extension 3 Filed

Oct 6, 2023

Sou Teas Extension Received

Apr 13, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 11, 2023

Sou Extension 2 Granted

Apr 11, 2023

Sou Extension 2 Filed

Apr 11, 2023

Sou Teas Extension Received

Oct 4, 2022

Notice Of Approval Of Extension Request E-Mailed

Sep 30, 2022

Sou Extension 1 Granted

Sep 30, 2022

Sou Extension 1 Filed

Sep 30, 2022

Sou Teas Extension Received

Apr 12, 2022

Noa E-Mailed - Sou Required From Applicant

Feb 15, 2022

Official Gazette Publication Confirmation E-Mailed

Feb 15, 2022

Published For Opposition

Jan 26, 2022

Notification Of Notice Of Publication E-Mailed

Jan 11, 2022

Law Office Publication Review Completed

Jan 11, 2022

Assigned To Lie

Jan 10, 2022

Approved For Pub - Principal Register

Jan 7, 2022

Teas/Email Correspondence Entered

Jan 7, 2022

Correspondence Received In Law Office

Jan 7, 2022

Teas Response To Office Action Received

Dec 30, 2021

Notification Of Non-Final Action E-Mailed

Dec 30, 2021

Non-Final Action E-Mailed

Dec 30, 2021

Non-Final Action Written

Dec 29, 2021

Assigned To Examiner

Aug 3, 2021

New Application Office Supplied Data Entered

May 3, 2021

New Application Entered